5,6-dihydroxy-2-methylaminotetralin has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Crommentuyn, KM; Huitema, AD; Kuijpers, TW; Mathôt, RA; Scherpbier, HJ | 1 |
1 other study(ies) available for 5,6-dihydroxy-2-methylaminotetralin and HIV Coinfection
Article | Year |
---|---|
Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Male; Nelfinavir; Netherlands; Risk Assessment; Severity of Illness Index; Tetrahydronaphthalenes; Treatment Outcome; Viral Load | 2006 |